Overview
Ceylon Tea Brokers is a licensed intermediary at the Colombo Tea Auction, broking and marketing teas across all elevations and offering advisory and working capital solutions to producers. The group also operates Logicare, a logistics subsidiary providing warehousing, transport and value-added services. With a market capitalisation of LKR 1.93 billion, CTBL is a small-cap services play on Sri Lanka’s tea value chain rather than a plantation owner. The most important change is operational: margins and quarterly profitability have strengthened through FY26-to-date after an FY25 loss, resetting expectations around earnings resilience and dividend capacity while drawing investor focus to execution and any portfolio moves around Logicare.
Price performance
The share gained 47.2% over 12 months, outpacing the broader market. Momentum cooled more recently, with a -11.7% 3-month return. It traded between LKR 7.20 and LKR 14.60 in the past year, consolidating below the mid-point. Beta to the ASPI is -0.491, indicating low co-movement rather than low risk. Liquidity is modest, with average 20-day volume of 17,444 shares, which can amplify moves around news or results. The setup describes a name that re-rated on improving fundamentals but is now digesting gains amid a weaker market tape.
Valuation
CTBL trades on 13.3x P/E versus a sector median 8.53x. P/B of 3.29 also sits well above the 1.21 sector median. Dividend yield is 5.7%, supported by ongoing payouts, which partly offsets the earnings multiple. Last reported ROE was -3.3%, so the premium multiples ask for continued earnings repair and cash generation to be justified. The valuation therefore prices in stability in tea auction activity and discipline on costs and capital, leaving less room for missteps than sector peers with lower expectations.
News and sentiment
There were no material articles in the last three months. Outside that window, the CSE imposed a penalty on 24 Feb 2026 under listing rules. On 10 Apr 2026 the company disclosed a transfer of shares in Logicare; details were limited and no financial terms were provided. The last confirmed dividend was LKR 0.60 per share, ex 4 Nov 2025. Overall, disclosure flow has been sparse, and clarity on the Logicare item would help investors assess any impact on mix, earnings and balance sheet flexibility.
Financials
In the quarter to 31 Mar 2026, gross margin was 67.9% versus 62.6% a year earlier. Operating margin improved to 28.9% from 24.7%. Net margin rose to 9.1% from 7.2% as operating gains fed through despite finance and tax drag. The trend marks a clear recovery from FY25, when the group fell into a loss for the year, and underscores healthier broking throughput and cost control. Equity remains modest for the market cap, and below-the-line items continue to weigh on conversion from operating to net earnings, so sustaining this improved margin mix is central to the story.
Risks
Tea-sector headwinds persist: labour shortages, mixed auction prices, weather-affected output and higher fertiliser costs can crimp volumes and fee pools. As a broker, CTBL is exposed to tea throughput and pricing cycles rather than commodity cultivation, but auction slowdowns would still pressure revenue. The CSE penalty highlights compliance and governance risk. A small equity base magnifies shocks and makes the premium P/B sensitive to sentiment. Uncertainty around the disclosed transfer of Logicare shares introduces potential execution and strategic risk until terms and rationale are clarified.
Outlook
The key watch is durability of the margin repair as auction activity normalises. Holding net margin around 9% or better would confirm that operating discipline and mix improvements are sticking. Any update on the Logicare share transfer could reshape the group’s earnings profile and capital needs. Easing interest rates may help below-the-line pressure, but tea volume and price dynamics remain the swing variables. Dividend headroom is limited; maintaining cover near 1.33x would support the current payout while incremental growth reduces valuation risk.